Grant: Doctoral: Vanier Canada Graduate Scholarships
McMaster University
$150,000.00
Emotion versus Cognition in Schizophrenia: Behaviourally Validating the Biology
FY 2009-10
Summary
Recent accounts of schizophrenia pathology have focused on the opposing influences of emotion and cognition. Several neural models have suggested that thought and behaviour patterns in schizophrenia are biased in a manner that places greater significance on the emotional qualities of a situation or task, at the expense of more important contextual elements. In other words, these biological models posit that emotional influences (whether real or perceived) hinder one's ability to appropriately deal with situational or task demands. To date, however, these presumptions have not been explored from a behavioural standpoint in patients. Thus, the purpose of the proposed research is to determine if the tenets of these biological models accurately predict the behaviour of schizophrenia patients on tasks that place emotional and cognitive processing in opposition. It is hypothesized that patients with schizophrenia will perform worse than controls on each task, and that emotionally-charged elements will only worsen their poorer cognitive performance. There are several tangible benefits to this research. For example, this could introduce a potential target for rehabilitative efforts aimed at improving day-to-day functioning. Specifically, therapy designed to deemphasize the influence of irrelevant emotional information may lead to patients more readily responding to everyday situations based on non-emotional, contextual information. Another realistic benefit is a more localized target for drug intervention. Should behavioural patterns validate what is predicted by the biological models, pharmaceutical agents could be manufactured to specifically target the dysfunctional brain regions in question, thus improving patient cognition and functional outcome. This, in concert with more refined therapies, promises to greatly increase patient autonomy, as well as reduce the financial burden that this disorder places on the Canadian healthcare system.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
197208
Name
Patrick Regan E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Emotion versus Cognition in Schizophrenia: Behaviourally Validating the Biology
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Behaviour; Cognition; Emotion; Neurobiology; Psychopathology; Schizophrenia
Abstract
Recent accounts of schizophrenia pathology have focused on the opposing influences of emotion and cognition. Several neural models have suggested that thought and behaviour patterns in schizophrenia are biased in a manner that places greater significance on the emotional qualities of a situation or task, at the expense of more important contextual elements. In other words, these biological models posit that emotional influences (whether real or perceived) hinder one's ability to appropriately deal with situational or task demands. To date, however, these presumptions have not been explored from a behavioural standpoint in patients. Thus, the purpose of the proposed research is to determine if the tenets of these biological models accurately predict the behaviour of schizophrenia patients on tasks that place emotional and cognitive processing in opposition. It is hypothesized that patients with schizophrenia will perform worse than controls on each task, and that emotionally-charged elements will only worsen their poorer cognitive performance. There are several tangible benefits to this research. For example, this could introduce a potential target for rehabilitative efforts aimed at improving day-to-day functioning. Specifically, therapy designed to deemphasize the influence of irrelevant emotional information may lead to patients more readily responding to everyday situations based on non-emotional, contextual information. Another realistic benefit is a more localized target for drug intervention. Should behavioural patterns validate what is predicted by the biological models, pharmaceutical agents could be manufactured to specifically target the dysfunctional brain regions in question, thus improving patient cognition and functional outcome. This, in concert with more refined therapies, promises to greatly increase patient autonomy, as well as reduce the financial burden that this disorder places on the Canadian healthcare system.
Competitiondate
200911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Patrick, Regan E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~